Article

FDA's Global Strategy Against Counterfeit Medications

Author(s):

Earlier this month, the FDA took steps to prevent the online sale of counterfeit and illegal medicinal products, which can be a significant health risk to the population.

Earlier this month, the FDA took steps to prevent the online sale of counterfeit and illegal medicinal products, which can be a significant health risk to the population.

Operation Pangea VIII, which spanned 115 countries, resulted in more than 2400 websites being taken offline and the seizure of $81 million worth of potential dangerous illegal medicines and medical devices worldwide. The current effort was a part of FDA's Global Strategic Framework for counterfeit and substandard medical products that strives to protect consumers by reducing their exposure to counterfeit and substandard medical products.

Read more about the FDA's effort on FDAVoice.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Gordon Crofoot, MD, PA
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Saad Z. Usmani, MD, MBA, FACP, FASCO, Memorial Sloan Kettering Cancer Center
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo